Covid lockdown: England sees fewer cases of colds, flu, and bronchitis

@article{Iacobucci2020CovidLE,
  title={Covid lockdown: England sees fewer cases of colds, flu, and bronchitis},
  author={Gareth Iacobucci},
  journal={BMJ},
  year={2020},
  volume={370}
}
Cases of common cold, flu, and other respiratory diseases in England are substantially lower than average for this time of year, GP surveillance data show. The Royal College of General Practitioners, which published the figures, derived from data from 500 practices across England,1 said that lockdown and physical distancing measures to prevent the spread of covid-19 were the probable cause of the trend. But although there were fewer respiratory diseases and other viral infections for this… 
6 Citations
COVID-19 and Infant Hospitalizations for Seasonal Respiratory Virus Infections, New Zealand, 2020
TLDR
New Zealand hospitalizations for lower respiratory tract infection among infants <2 years of age and cases of respiratory syncytial or influenza virus infection have dramatically decreased, and findings indicate additional benefits of coronavirus disease control strategies.
Upsurge of human rhinovirus infection followed by a delayed seasonal respiratory syncytial virus infection in Thai children during the coronavirus pandemic
TLDR
This work aimed to characterize the upsurge of HRV and the subsequent RSV infection observed among young children who sought medical care at a hospital in Bangkok.
Should countries aim for elimination in the covid-19 pandemic?
TLDR
The cost to quality of life years is too big a risk when “possible” is not the same as “achievable”, argues Simon Thornley, Arthur J Morris, and Gerhard Sundborn.
Changes in gynecologic and breast cancer diagnoses during the first wave of the COVID-19 pandemic: analysis from a tertiary academic gyneco-oncological center in Germany
TLDR
This analysis illustrates the anticipated general decrease in diagnoses of primary cancers during the lockdown periods in 2020 due to COVID-19 pandemic for gynecologic and breast cancer cases.
Viral kinetic modeling and clinical trial simulation predicts disruption of respiratory disease trials by non-pharmaceutical COVID-19 interventions
TLDR
An epidemiological model of respiratory tract infection sensitive to a time dependent between-host transmission rate and coupled this model to a mechanistic description of viral RTI episodes in an individual patient is set up and model predictions can help rationalize and forecast post-COVID-19 trial feasibility.